Stocks · Healthcare · Biotechnology
Alpha Cognition Inc ACOG
$9.10 +4.60% Close, Oct 2, 2026 · NASDAQ · Market cap $141.3M
Strong trend
Next earnings report: Nov 12, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $15.3M, up 232.7% from a year earlier, slowing from 269.6% a quarter earlier.
- Operating margin widened to -190.6% from -298.3% a year earlier.
- The diluted share count rose 35.9% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 6%
- Revenue growth accelerationBottom 8%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 26%
- Gross marginTop 19%
- Operating marginBottom 24%
- Accruals (lower is better)Bottom 6%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 42%
- Free-cash-flow yieldBottom 23%
- EBITDA / enterprise valueBottom 24%
- Sales / enterprise valueBottom 41%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 46%
- 6-month returnTop 18%
- 1-year return vs S&P 500Top 41%
- Distance from 52-week highTop 16%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 24%
- Consecutive EPS beatsBottom 20%
- Upside to consensus price targetTop 40%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 43%
- Maximum drawdown, 3 yearsTop 35%
- Beta vs S&P 500 (lower is better)Bottom 11%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 269.6% | 232.7% | ↓ |
| Gross margin | 70.1% | 89.9% | ↑ |
| Operating margin | -298.3% | -190.6% | ↑ |
| FCF margin | -264.8% | -204.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 232.7% | 269.6% | ↓ | Top 6% |
| Gross margin | 89.9% | 70.1% | ↑ | Top 19% |
| Operating margin | -190.6% | -298.3% | ↑ | Bottom 24% |
| Net margin | -153.6% | -436.4% | ↑ | — |
| Free-cash-flow margin | -204.6% | -264.8% | ↑ | — |
| Return on invested capital | -50.0% | — | Bottom 26% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 11.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 24.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -52.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -27.69%
- Shareholder yield
- -27.69%
- Share count change, 1 year
- +35.9%
- Share count change, 3-year CAGR
- +79.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +19.4%
- Average 2-day reaction, last 8
- -4.7%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $17.25
- Target vs current price
- +89.6%
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | -2.0% | -3.6% | -0.7% | -0.6% | — |
| May 14, 2026 | +9.8% | -4.5% | -1.0% | +1.5% | +49.4% |
| Mar 26, 2026 | -11.1% | +0.4% | +12.0% | +28.8% | +27.1% |
| Nov 13, 2025 | +81.0% | +0.2% | -3.3% | -4.7% | -12.3% |
| Aug 14, 2025 | -41.3% | -19.9% | -19.9% | -2.1% | -42.9% |
| May 15, 2025 | +65.5% | -0.7% | +43.6% | +40.1% | +45.6% |
| Mar 31, 2025 | -6.3% | -8.5% | -12.7% | -9.4% | +73.1% |
| Nov 14, 2024 | +69.0% | -1.0% | +0.7% | +0.0% | +1.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.40 | -$0.39 | -2.0% | $6.0M |
| May 14, 2026 | -$0.37 | -$0.41 | +9.8% | $3.5M |
| Mar 26, 2026 | -$0.30 | -$0.27 | -11.1% | $2.8M |
| Nov 13, 2025 | -$0.08 | -$0.43 | +81.0% | $2.8M |
| Aug 14, 2025 | -$0.65 | -$0.46 | -41.3% | $1.7M |
| May 15, 2025 | -$0.20 | -$0.58 | +65.5% | $2.9M |
| Mar 31, 2025 | -$0.51 | -$0.48 | -6.3% | — |
| Nov 14, 2024 | -$0.31 | -$1.00 | +69.0% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 6.55× | — | — | Bottom 41% |
| Free-cash-flow yield | -22.09% | — | — | Bottom 23% |
| Earnings yield | -12.20% | — | — | Bottom 42% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 1
- Days above the 200-day average
- 75
- 50-day average slope (20 days)
- +4.5%
- 200-day average slope (20 days)
- +4.5%
- Distance from 50-day average
- +1.9%
- Distance from 200-day average
- +32.2%
- RSI (14)
- 54.3
- Relative volume
- 1.84×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 51.8%
- Volatility vs own 5-year history
- 1th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.08
- Correlation with S&P 500
- 0.42
- Current drawdown from 1-year high
- -6.7%
- Maximum drawdown, 3 years
- -60.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 7, 2024 | Apr 8, 2025 | -60.3% | 102 days | 28 days (May 19, 2025) |
| Jul 7, 2025 | Feb 5, 2026 | -60.0% | 148 days | Not yet recovered |
| May 20, 2025 | May 28, 2025 | -20.3% | 5 days | 24 days (Jul 2, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $141.3M
- EPS, diluted (TTM)
- -$1.11
- Revenue (TTM)
- $15.3M
- 52-week range
- $4.50 – $10.14
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $10.2M |
| Gross profit | $0 | $0 | $0 | $0 | $8.3M |
| Operating income | -$14.7M | -$18.1M | -$9.6M | -$11.9M | -$22.7M |
| Net income | -$24.9M | -$16.3M | -$13.8M | -$14.6M | -$20.7M |
| EPS (diluted) | -$11.79 | -$6.05 | -$3.84 | -$2.02 | -$1.17 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $2.9M | $1.7M | $2.8M | $2.8M | $3.5M | $6.1M |
| Net income | -$1.9M | -$5.7M | -$2.0M | -$10.5M | -$1.3M | -$6.9M | -$6.5M | -$8.8M |
| EPS (diluted) | -$0.31 | -$0.51 | -$0.13 | -$0.65 | -$0.08 | -$0.31 | -$0.32 | -$0.40 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$12.6M | -$12.4M | -$8.7M | -$7.8M | -$20.4M |
| Capital expenditure | -$81,141 | -$6,552 | -$5 | -$26,701 | -$293,489 |
| Free cash flow | -$12.7M | -$12.4M | -$8.7M | -$7.8M | -$20.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $17.4M | $0 | $9.2M | $56.5M | $41.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $41.4M
- Total assets
- $64.5M
- Total liabilities
- $11.6M
- Total debt
- $0
- Net debt
- -$41.4M
- Shareholders’ equity
- $53.0M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 209,226
- Days to cover
- 2.22
- Change vs previous report
- -1.0%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 5, 2024
- 1-for-25